Overview
Seer Q3 2025 revenue rose 2% yr/yr to $4.1 mln, driven by product and service sales
Net loss for Q3 2025 was $18.2 mln, an improvement from $21.3 mln last year
Company saw robust demand for Proteograph ONE, increasing instrument shipments
Outlook
Seer expects full-year 2025 revenue between $17 mln and $18 mln
Result Drivers
PROTEOGRAPH DEMAND - Robust demand for Proteograph ONE workflow drove increased instrument shipments
PUBLICATION RECORD - Record number of third-party publications validating Proteograph technology
PRODUCT SALES - Higher product sales contributed to revenue growth
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
$4.12 mln
Q3 EPS
-$0.32
Q3 Net Income
-$18.23 mln
Q3 Gross Margin
51.00%
Q3 Gross Profit
$2.11 mln
Q3 Operating Expenses
$21.46 mln
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the office equipment peer group is "buy"
Press Release: ID:nGNX6McLPS
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)